Dupixent (dupilumab)

pCPA File Number: 22214
Negotiation Status:
Concluded with an LOI
Indication(s):
atopic dermatitis
Sponsor/Manufacturer:
sanofi-aventis Canada Inc.
CADTH Project Number:
SF0754
pCPA Engagement Letter Issued:
Negotiation Process Concluded: